Dan Brennan
Stock Analyst at TD Cowen
(4.42)
# 327
Out of 5,090 analysts
120
Total ratings
56.84%
Success rate
18%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.60 | +94.44% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $396.22 | -1.57% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $101.16 | -11.03% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $7.11 | +26.58% | 2 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Hold | $40 → $42 | $48.05 | -12.59% | 2 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Hold | $110 → $115 | $128.64 | -10.60% | 13 | Oct 31, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $571.95 | +14.35% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $227.21 | +14.43% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $145.09 | +11.65% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $102.14 | -29.51% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $11.81 | +1.61% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $15.06 | -0.40% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $28.65 | +11.69% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $157.63 | -30.22% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.74 | -33.07% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $76.83 | -3.68% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $243.33 | -28.08% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $184.72 | +35.34% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $101.43 | +41.97% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $10.98 | +182.33% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $41.80 | +22.01% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $7.79 | +618.82% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $17.52 | +82.65% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $190.93 | +185.97% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.37 | +534.25% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $185.56 | +25.03% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,411.71 | -37.66% | 3 | Oct 7, 2020 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.60
Upside: +94.44%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $396.22
Upside: -1.57%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $101.16
Upside: -11.03%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $7.11
Upside: +26.58%
Bruker
Nov 4, 2025
Maintains: Hold
Price Target: $40 → $42
Current: $48.05
Upside: -12.59%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $110 → $115
Current: $128.64
Upside: -10.60%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $571.95
Upside: +14.35%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $227.21
Upside: +14.43%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $145.09
Upside: +11.65%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $102.14
Upside: -29.51%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $11.81
Upside: +1.61%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $15.06
Upside: -0.40%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $28.65
Upside: +11.69%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $157.63
Upside: -30.22%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.74
Upside: -33.07%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $76.83
Upside: -3.68%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $243.33
Upside: -28.08%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $184.72
Upside: +35.34%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $101.43
Upside: +41.97%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $10.98
Upside: +182.33%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $41.80
Upside: +22.01%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $7.79
Upside: +618.82%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $17.52
Upside: +82.65%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $190.93
Upside: +185.97%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.37
Upside: +534.25%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $185.56
Upside: +25.03%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,411.71
Upside: -37.66%